Cargando…
Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models
A novel pathway of vitamin D(3) (D(3)) metabolism, initiated by C20-hydroxylation of D(3) by CYP11A1, has been confirmed to operate in vivo. Its major product, 20(OH)D(3), exhibits antiproliferative activity in vitro comparable to that of 1,25(OH)(2)D(3), but is noncalcemic in mice and rats. To furt...
Autores principales: | Skobowiat, Cezary, Oak, Allen S.W., Kim, Tae-Kang, Yang, Chuan He, Pfeffer, Lawrence M., Tuckey, Robert C., Slominski, Andrzej T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354773/ https://www.ncbi.nlm.nih.gov/pubmed/28039464 http://dx.doi.org/10.18632/oncotarget.14193 |
Ejemplares similares
-
Ultraviolet B (UVB) activates hypothalamic-pituitary-adrenal (HPA) axis in C57BL/6 mice
por: Skobowiat, Cezary, et al.
Publicado: (2014) -
RORα and RORγ expression inversely correlates with human melanoma progression
por: Brożyna, Anna A., et al.
Publicado: (2016) -
20S-Hydroxyvitamin D3, a Secosteroid Produced in Humans, Is Anti-Inflammatory and Inhibits Murine Autoimmune Arthritis
por: Postlethwaite, Arnold E., et al.
Publicado: (2021) -
Current Molecular Markers of Melanoma and Treatment Targets
por: Yang, Kevin, et al.
Publicado: (2020) -
CYP24A1 Expression Inversely Correlates with Melanoma Progression: Clinic-Pathological Studies
por: Brożyna, Anna A., et al.
Publicado: (2014)